# FDA Inspection 620215 - CSL Plasma Inc. - September 25, 2009

Source: https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/9af6d2a5-b348-42f1-96bf-e3d671787e0d
Source feed: FDA_Inspections

> FDA Inspection 620215 for CSL Plasma Inc. on September 25, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 620215
- Company Name: CSL Plasma Inc.
- Inspection Date: 2009-09-25
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1083413 - 2019-02-27](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/a7cc165d-8eb5-448d-8fb4-223ac5a2bd14)
- [FDA Inspection 958733 - 2016-02-10](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/a68f1e6f-600b-4dd5-aa47-7e3da8105e57)
- [FDA Inspection 817543 - 2013-01-31](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/77379e6e-2e0c-4c5c-b089-073400dc3b94)

Company: https://www.keypedia.com/companies/csl-plasma-inc/2ec9ca3b-af06-4275-b981-c7912584e974

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d